Best Life Sciences Companies in Birmingham, United States
The 42 best Life Sciences companies in Birmingham, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Immunowake.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Birmingham
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Immunowake Developer of antibody-based therapeutics for the treatment of cancer | $20M | 51 mo ago | Seed | 2 | 2019 | Xiaoyun Wu Co-Founder | 34 patents Engineered cytokine‑antibody fusion proteins for targeted immune modulation in cancer therapy | — |
| 2 | Resbiotic Provider of probiotic supplements to improve health | $10M | 11 mo ago | Series A | 11 | 2021 | — | — | 1 partnership · 1 award |
| 3 | FirstSense Medical Radiation free point-of-care diagnostics device for breast cancer | $10M | 116 mo ago | Series A | 12 | 2008 | Paul Angott Founder & President | — | — |
| 4 | Gem Pharmaceuticals Specialty company developing anthracycline derivatives to eliminate cardiotoxicity side effect | $4M | 149 mo ago | Acqui-Hired | — | 2003 | Gerald M Walsh CEO | — | — |
| 5 | XpertDox AI powered medical coding and clinical trials solutions provider | $4M | 43 mo ago | Seed | 34 | 2015 | Bhupesh Panwar Co-Founder & COO | 2 patents AI-driven recommendation systems for hospitals and physicians in healthcare informatics | 2 awards |
| 6 | Vector Logics Oncolytic virus-based immunotherapies for ovarian cancers | $3M | 203 mo ago | Deadpooled | — | 1998 | David Curiel Founder | — | — |
| 7 | Reliant Glycosciences Developer of diagnostic assays for chronic kidney disease | $2M | 26 mo ago | Funding Raised | 4 | 2015 | Dana Rizk Co-Founder | — | — |
| 8 | Preventric Developer of a screening device for hypertension and vascular diseases | $2M | 62 mo ago | Deadpooled | 3 | 2019 | Philip White Founder & Chairman | — | — |
| 9 | Vivo Biosciences Biotech company pioneering 3D bioassays for drug discovery and therapeutics | $2M | 145 mo ago | Acquired | — | 2004 | Raj Singh CEO & President | — | — |
| 10 | TriAltus Bioscience Simplified protein purification solutions, delivering ultra-pure, high-performance proteins and genomic… | $2M | 47 mo ago | Seed | 8 | 2017 | Dmitry Vassylyev Co-Founder & CSO | — | — |
| 11 | Blondin Bioscience Developer of telomere-based liquid biopsy tests | $2M | 129 mo ago | Funding Raised | — | 2011 | Katri Selander Founder & CSO | — | — |
| 12 | BioHorizons Developer of dental implant technologies and tissue regeneration products | $2M | 164 mo ago | Acquired | 331 331 → 500 (+51%) | 1994 | — | — | 4 launchs |
| 13 | Movi Medical Wheelchairs for patient transportation | $1M | 108 mo ago | Seed | 14 | 2012 | Lloyd Cooper Founder | — | — |
| 14 | CerFlux Provider of personalized cancer treatment selection tests. | $1M | 37 mo ago | Seed | 8 | 2015 | Karim Budhwani CEO | 14 patents Patents concentrated in computing, sensing & instrumentation | — |
| 15 | Atherotech Medical technology news, insights, and updates from around the globe | $999K | 202 mo ago | Acquired | 471 | 1994 | Jim McClintic CEO | 20 patents Clinical diagnostics for serum lipoprotein profiling and cell‑free nucleic acid assays | — |
| 16 | Moremme Developer of hormone-free, natural vaginal health products | $870K | 17 mo ago | Funding Raised | — | 2021 | Ore Adedoyin Co-Founder | — | — |
| 17 | 3PH Alliance Provider of data analytics platform for healthcare practices | $400K | 45 mo ago | Funding Raised | 5 | 2020 | Jose Osorio Founder and CMO | — | 1 partnership · 1 award |
| 18 | Nutech Medical Biologic and medical device company focusing on spinal and orthopedic surgical products | $325K | 186 mo ago | Acqui-Hired | 40 | 1994 | — | — | — |
Top 12 Life Sciences companies in Birmingham
#1
Series A · Birmingham, Alabama · founded 2021 · 11 employees$10.1Mraised▾
Provider of probiotic supplements to improve health. It offers physician-formulated supplements including probiotics, prebiotics, and postbiotics aimed at restoring gut health and supporting lung, gut, and metabolic wellness.
- Sep 2025Series A$8M
- Feb 2025Seed$2.5M
- Jan 2024Seed$2.6M
- Mar 2023Grant (prize money)$1.3M
#2
Funding Raised · Birmingham, Alabama · founded 2021$870.3Kraised▾
Developer of hormone-free, natural vaginal health products. These products are scientifically designed to maintain and revitalize vaginal health, focusing on pH balance, hydration, and repair. The company aims to boost women's confidence and comfort through its inclusive approach to intimate care solutions. A suite of plant-powered intimate therapeutics is planned for future release.
- Mar 2025Grant (prize money)$470.6K
- Aug 2024Grant (prize money)$399.8K
#3
Funding Raised · Birmingham, Alabama · founded 2015 · 4 employees$2.5Mraised▾
Developer of diagnostic assays for chronic kidney disease. The company offers proprietary biomarker-based tools IgA Nephropathy (IgAN) for the detection of nephropathy. The technology can detect the presence of Galactose-deficient IgA1 (Gd-IgA1) and an auto-antibody that recognizes Gd-IgA1.
- Jun 2024Grant (prize money)$977.8K
- Sep 2022Grant (prize money)—
- Jul 2020Grant (prize money)$1.5M
#4
Seed · Birmingham, Alabama · founded 2019 · 2 employees$20Mraised▾
Developer of antibody-based therapeutics for the treatment of cancer. The company is focused on the generation of multi-target antibodies against cancer. The company uses VEGF-Trap and CD3 Bi-specific platforms to design PD-L1 antibodies for the development of multi-target therapeutics.
- May 2022Seed$20M
#5
Seed · Birmingham, Alabama · founded 2015 · 34 employees$3.6Mraised▾
AI powered medical coding and clinical trials solutions provider. The company's solutions include an autonomous coding solution accelerates the revenue cycle, The features include search engine, patient recruitment, and trial management and physician-facing internal platform for automated pre-screening, referral, and recruitment.
- Jan 2023Seed$1.1M
- Sep 2022Seed$1.5M
- Feb 2018Seed$1M
- Apr 2016Grant (prize money)$40K
#6
Seed · Birmingham, Alabama · founded 2015 · 8 employees$1.1Mraised▾
{}
- Aug 2023Grant (prize money)$275K
- Aug 2022Grant (prize money)$100K
- Jan 2021Seed$1M
- Dec 2020Grant (prize money)$50K
#7
Series A · Birmingham, Michigan · founded 2008 · 12 employees$9.9Mraised▾
FirstSense Medical develops a radiation-free point-of-care diagnostics device for breast cancer. Its proprietary platform uses advanced thermal profiling, in place of traditional spectroscopy to assess breast tissue for abnormalities. It then uses advanced computational algorithms to compare results with the other database. The company offers its robotic software for non-invasive, painless, radiation-free technology for early detection of breast cancer. The device Sentinel BreastScan is used for thermology screening and is FDA cleared.
- Dec 2016Series A$1.4M
- Sep 2016Series A$135K
- Dec 2015Series A$36K
- May 2015Series A$3.3M
#8
Seed · Birmingham, Alabama · founded 2017 · 8 employees$1.6Mraised▾
Simplified protein purification solutions, delivering ultra-pure, high-performance proteins and genomic enzymes. They offer recombinant protein solutions using their patented CLīM™ technology, enabling single-step purification for difficult proteins. Their offerings include a catalog of genomic enzymes like CRISPR Cas9 and custom protein production services tailored to specific needs. They focus on high purity, yield, and activity, providing cost-effective solutions for biotech and life science companies. They provide services like schedule a meeting, contact us, login, search, subscribe. The company's ISO-compliant manufacturing ensures reliable and affordable protein production at scale. They offer products and services in the B2B space.
- Sep 2022Grant (prize money)—
- Sep 2021Grant (prize money)$256.6K
- Apr 2019Seed$1.6M
#9
Deadpooled · Birmingham, Alabama · founded 2019 · 3 employees$2.1Mraised▾
Developer of a screening device for hypertension and vascular diseases. The non-invasive device BPro captures arterial pulse waves and generates a report according to various blood pressure indices. It uses machine learning and AI for the measurements of ambulatory blood pressure.
- Jun 2021Seed$50K
- Aug 2020Seed$2.1M
- Jul 2019Seed$2.2M
#10
Acqui-Hired · Birmingham, Alabama · founded 2003$4.5Mraised▾
Gem Pharmaceuticals is developing proprietary anthracycline derivatives designed to eliminate the critical cardiotoxicity side effect of chemotherapeutics while maintaining their anti-cancer efficacy. Gem effectively transforms traditional broad-spectrum cytotoxic drugs into modern - and biochemically targeted - anti-cancer agents that hold the potential for higher dosing and correspondingly improved therapeutic utility. Its anthracycline-modification platform can also be used to generate derivatives that could serve as long-term therapies for psoriasis, rheumatoid arthritis, and other T-cell mediated disorders
- Mar 2014Series A$4.5M
#11
Deadpooled · Birmingham, Alabama · founded 1998$2.7Mraised▾
VectorLogics was acquired & merged with DNAtriX in Oct 2012. The company had focused on developing therapies for the treatment of ovarian cancer. The company was working on oncolytic virus-based immunotherapies for cancers.
- Sep 2009Grant (prize money)$865K
- Sep 2008Grant (prize money)$865K
- Jul 2008Grant (prize money)$100K
- Mar 2005Grant (prize money)$865K
#12
Acquired · Birmingham, Alabama · founded 2004$2Mraised▾
Biotech company pioneering 3D bioassays for drug discovery and therapeutics. They focus on preclinical research, drug discovery, and therapeutics using patented HuBiogel technology, emulating normal and disease tissues in vitro. They offer 3D or Mini-tumor bioassay systems for rapid analysis of drug efficacy, toxicity, and therapy prediction. Their technology is offered worldwide to academic, commercial, and government institutions. They are involved in selective androgen receptor modulators (SARMs) & Peptides development, cannabinoids research, and in-vitro research procedures on all cannabinoids and research chemicals. They provide services like drug screening, gene profiling, stem cell research, tissue regeneration, and personalized medicine. They offer ready-to-use HuBiogel, Angio-Start Assay Kit, and custom products like High Density HuBiogel and HuBiogel-Coated Plates/Inserts. Their 3D HuBiogel assay enhances drug discovery, offering a versatile platform that bridges the gap between in vitro and in vivo research, empowering scientists to make more accurate predictions and streamline drug development.
- Aug 2014Grant (prize money)$157K
- Apr 2014Grant (prize money)$217.3K
- Dec 2013Grant (prize money)—
- Sep 2012Grant (prize money)$50K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Birmingham is moving
A read on the academic research around Biotechnology in Birmingham — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 54 papers.
- University of Birmingham27
- University of Alabama at Birmingham21
- Birmingham Dental Hospital3
- NIHR Birmingham Biomedical Research Centre3
- Birmingham Women\'s Hospital2
- Cell biology3
- Promoter2
- Immunology2
- Transcription (linguistics)2
- RNA polymerase2
- Gene3
- Transcriptome2
- Cell culture2
- Gene expression2
- Plant breeding2
- Agriculture2
- Telomere1
- Antiparallel (mathematics)1
- Ribonucleotide1
- RNase P1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.